These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 38817663

  • 1. Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress.
    Li YF, Zheng FY, Miao XY, Liu HL, Zhang YY, Chao NX, Mo FR.
    World J Gastroenterol; 2024 May 21; 30(19):2564-2574. PubMed ID: 38817663
    [Abstract] [Full Text] [Related]

  • 2. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z, Yin L, Zhou H, Ji X, Jiang C, Zhu X, He X.
    Cell Oncol (Dordr); 2021 Oct 21; 44(5):1035-1049. PubMed ID: 34176092
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of FAM134B inhibits endoplasmic reticulum stress-related degradation protein expression and promotes hepatocellular carcinogenesis.
    Wang H, Liu L, Gong H, Li H.
    J Cell Mol Med; 2024 Mar 21; 28(5):e17964. PubMed ID: 37728036
    [Abstract] [Full Text] [Related]

  • 4. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y, Zhou Q, Zhao C, Li J, Yu Z, Zhu Q.
    J Cell Mol Med; 2021 Feb 21; 25(3):1468-1479. PubMed ID: 33393219
    [Abstract] [Full Text] [Related]

  • 5. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S, Peng F, Ning Y, Jiang P, Peng J, Ding X, Zhang J, Jiang T, Xiang S.
    J Cell Biochem; 2020 Mar 21; 121(3):2543-2558. PubMed ID: 31696971
    [Abstract] [Full Text] [Related]

  • 6. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway.
    Tian L, Huang Y, Liu Y, Liu J, Liu Y.
    IUBMB Life; 2024 Nov 21; 76(11):972-986. PubMed ID: 38873890
    [Abstract] [Full Text] [Related]

  • 7. Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest.
    Li QZ, Chen YY, Liu QP, Feng ZH, Zhang L, Zhang H.
    Phytomedicine; 2024 Apr 21; 126():155177. PubMed ID: 38412667
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X, Zhang P, Pan Y, Liu Y.
    Yonsei Med J; 2020 Jun 21; 61(6):460-470. PubMed ID: 32469170
    [Abstract] [Full Text] [Related]

  • 9. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T, Huang C.
    Oncotarget; 2015 Jun 30; 6(18):16227-38. PubMed ID: 26023735
    [Abstract] [Full Text] [Related]

  • 10. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo.
    Kang X, Wang F, Lan X, Li X, Zheng S, Lv Z, Zhuang Y, Zhao Y, Zhou S.
    Int J Med Sci; 2018 Jun 30; 15(1):69-76. PubMed ID: 29333089
    [Abstract] [Full Text] [Related]

  • 11. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
    Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ.
    BMC Cancer; 2011 Apr 22; 11():150. PubMed ID: 21513518
    [Abstract] [Full Text] [Related]

  • 12. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
    Sun WJ, Huang H, He B, Hu DH, Li PH, Yu YJ, Zhou XH, Lv Z, Zhou L, Hu TY, Yao ZC, Lu MD, Shen X, Zheng ZQ.
    Biochem Pharmacol; 2017 Mar 01; 127():90-100. PubMed ID: 28012958
    [Abstract] [Full Text] [Related]

  • 13. Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.
    Liao S, Wang Q, Chen S, Huang Q, Zhou L, Liu H, He S, Zhou Z.
    J Transl Med; 2024 Aug 28; 22(1):792. PubMed ID: 39198815
    [Abstract] [Full Text] [Related]

  • 14. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X, Liu L, Zou H, Zheng YW, Wang KP.
    Dig Liver Dis; 2019 Oct 28; 51(10):1446-1455. PubMed ID: 31147216
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H, Liu J, Zou R, Cheng P, Su Y.
    J Exp Clin Cancer Res; 2019 May 09; 38(1):189. PubMed ID: 31072375
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY, Sun QC, Zou XJ, Song Y, Li WW, Guo ZQ, Liu SS, Liu L, Wu DH.
    J Exp Clin Cancer Res; 2020 Oct 29; 39(1):229. PubMed ID: 33121524
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ.
    Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185
    [Abstract] [Full Text] [Related]

  • 18. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
    Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, Guan W, Zhou J, Wu Y, Qiu Y, Ding Y.
    Oncol Rep; 2015 Aug 02; 34(2):823-32. PubMed ID: 26081192
    [Abstract] [Full Text] [Related]

  • 19. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W, Chen X, Chi W, Xue M.
    Int J Mol Med; 2020 Nov 02; 46(5):1743-1754. PubMed ID: 33000222
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X, Li W, Hu P, Jiang B, Yang J, Zhou L, Mao X, Tian B.
    Biosci Rep; 2020 Oct 30; 40(10):. PubMed ID: 33078826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.